TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15924593

Group type: EXPERIMENTAL
Intervention: On-demand esomeprazole 20 mg
Number of subjects: 2156

Group type: EXPERIMENTAL
Intervention: Continuous esomeprazole 20 mg once-daily
Number of subjects: 2156

Group type: COMPARATOR
Intervention: Continuous ranitidine 150 mg twice-daily
Number of subjects: 2156
Study: 12765745

Group type: EXPERIMENTAL
Intervention: Melperone 100 mg/day
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Melperone 400 mg/day
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Melperone (both doses)
Number of subjects: 34
Study: 10665128

Group type: EXPERIMENTAL
Intervention: Milk fermented by Lactobacillus casei (strain DN-114 001)
Number of subjects: 287

Group type: COMPARATOR
Intervention: Jellied milk (control product)
Number of subjects: 287
Study: 10163302

Group type: EXPERIMENTAL
Intervention: School-based interventions
Number of subjects: 6000

Group type: EXPERIMENTAL
Intervention: School-plus-family interventions
Number of subjects: 6000

Group type: COMPARATOR
Intervention: Control
Number of subjects: 6000
Study: 1888325

Group type: EXPERIMENTAL
Intervention: Social Skills Training (SST)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Rational Emotive Therapy (RET)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Confederate ratings of overt behavior on the SSIT
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Treatment effectiveness
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Relapse factors
Number of subjects: 57
Study: 6864377

Group type: EXPERIMENTAL
Intervention: 100 to 300 micrograms nebulized fenoterol
Number of subjects: 31

Group type: COMPARATOR
Intervention: 0, 100, 300, and 1000 micrograms nebulized fenoterol
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 3, 10, 30, or 100 micrograms nebulized fenoterol
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 3 to 1000 micrograms nebulized fenoterol
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 2 and 3 hours after administration
Number of subjects: 31
Study: 31068332

Group type: EXPERIMENTAL
Intervention: Hand-held fan
Number of subjects: 41
Study: 28701205

Group type: EXPERIMENTAL
Intervention: Art therapy
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Music reminiscence activity
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Both interventions (Art therapy and Music reminiscence)
Number of subjects: 90
Study: 26463607

Group type: EXPERIMENTAL
Intervention: Ulinastatin (5,000 U/kg intravenous injection before skin incision and at the end of operation)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Ulinastatin
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no ulinastatin)
Number of subjects: 48
Study: 22920723

Group type: EXPERIMENTAL
Intervention: Porcine placental extract (PPE) - 3 capsules/day for the first 12 weeks, then 6 capsules/day for the next 12 weeks
Number of subjects: 76

Group type: COMPARATOR
Intervention: Toki-shakuyaku-san (TJ23) - control group, 24 weeks of open treatment
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Porcine placental extract (PPE)
Number of subjects: 76
Study: 21718270

Group type: EXPERIMENTAL
Intervention: High-intensity functional weight‐bearing exercise program
Number of subjects: 191

Group type: COMPARATOR
Intervention: Control activity
Number of subjects: 191
Study: 19139666

Group type: COMPARATOR
Intervention: Anterior cervical discectomy and fusion with allograft and plate
Number of subjects: 488
Study: 17566395

Group type: EXPERIMENTAL
Intervention: Sharp expansion of the uterus using scissors
Number of subjects: 300

Group type: COMPARATOR
Intervention: Blunt expansion of the uterus using surgeon's indexes
Number of subjects: 300
Study: 15842594

Group type: EXPERIMENTAL
Intervention: Sedation (meperidine 62.5 mg and midazolam 2.5 mg)
Number of subjects: 17

Group type: COMPARATOR
Intervention: No Sedation
Number of subjects: 17
Study: 12456070

Group type: EXPERIMENTAL
Intervention: Cerebrolysin (Cere) 30 ml infusion, five days/week for six weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo infusion, five days/week for six weeks
Number of subjects: 0
Study: 10397380

Group type: EXPERIMENTAL
Intervention: Torsemide
Number of subjects: 240

Group type: COMPARATOR
Intervention: Furosemide
Number of subjects: 240
Study: 8759491

Group type: EXPERIMENTAL
Intervention: Gold or methotrexate (MTX) therapy
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 11
Study: 1882158

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment (specific antibiotics not mentioned)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Various antibiotics tested (specifics not mentioned)
Number of subjects: 21
Study: 6415511

Group type: EXPERIMENTAL
Intervention: Valproate (VPA)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Phenytoin (PHT)
Number of subjects: 61
Study: 31468247

Group type: EXPERIMENTAL
Intervention: Environmental changes made by RCH staff to increase FV intake
Number of subjects: 614

Group type: EXPERIMENTAL
Intervention: Post-intervention mean servings of FV intake
Number of subjects: 614
Study: 30526198

Group type: EXPERIMENTAL
Intervention: Vorapaxar
Number of subjects: 12944

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12944
Study: 26747038

Group type: EXPERIMENTAL
Intervention: Bristol Girls Dance Project (BGDP) - a 20-week school-based intervention consisting of two 75 min after-school dance sessions per week.
Number of subjects: 571

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 571
Study: 25092393

Group type: EXPERIMENTAL
Intervention: 30-mg fimasartan
Number of subjects: 293

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 293
Study: 21816445

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention program consisting of an unsupervised walking exercise for 4 months in NGT individuals.
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Caffeine or palmitate exposure in cultured skeletal muscle.
Number of subjects: 112

Group type: COMPARATOR
Intervention: T2DM patients (control group).
Number of subjects: 112
Study: 20308769

Group type: EXPERIMENTAL
Intervention: Cholecalciferol granules (60,000 IU) orally once in two months (two‐monthly D₃ group)
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Cholecalciferol granules (60,000 IU) orally once a month (one‐monthly D₃ group)
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Cholecalciferol granules (60,000 IU) orally once in two months (two‐monthly D₃ group) in USES subjects
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Cholecalciferol granules (60,000 IU) orally once a month (one‐monthly D₃ group) in USES subjects
Number of subjects: 290
Study: 17046964

Group type: EXPERIMENTAL
Intervention: Adalimumab (40 mg every other week)
Number of subjects: 313
Study: 16286532

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet
Number of subjects: 129

Group type: COMPARATOR
Intervention: Standard diet
Number of subjects: 129
Study: 12172406

Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg
Number of subjects: 721

Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg
Number of subjects: 721

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 721
Study: 10212791

Group type: EXPERIMENTAL
Intervention: Intra-arterial chemotherapy combined with radiotherapy
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Intra-arterial chemotherapy
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: All patients
Number of subjects: 83
Study: 7597118

Group type: EXPERIMENTAL
Intervention: SOC-LOW
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: SOC-HIGH
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: ISO-LOW
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: ISO-HIGH
Number of subjects: 41
Study: 2112877

Group type: EXPERIMENTAL
Intervention: 100 mg recombinant tissue‐type plasminogen activator (rt‐PA) intravenously over 3 hours
Number of subjects: 721

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 721
Study: 306577

Group type: EXPERIMENTAL
Intervention: Oral metronidazole
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Oral ampicillin
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Oral doxycycline
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Sulfonamide vaginal cream
Number of subjects: 123

Group type: COMPARATOR
Intervention: Persistent H. vaginalis infection
Number of subjects: 123

Group type: COMPARATOR
Intervention: No persistent H. vaginalis infection
Number of subjects: 123
Study: 29253700

Group type: EXPERIMENTAL
Intervention: Simulation Training (ST) group
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 10
Study: 27594381

Group type: EXPERIMENTAL
Intervention: Probiotic Bifidobacterium breve BBG-001 (6.7 × 10(7) to 6.7 × 10(9) CFU per dose)
Number of subjects: 1315

Group type: COMPARATOR
Intervention: Placebo (1 ml of one‐eighth‐strength infant formula Neocate)
Number of subjects: 1315
Study: 24281852

Group type: EXPERIMENTAL
Intervention: Flavonoid intake
Number of subjects: 1778

Group type: EXPERIMENTAL
Intervention: Hierarchical model
Number of subjects: 1778
Study: 24384995

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (200,000 IU)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study: 19484402

Group type: EXPERIMENTAL
Intervention: Extraoral LLLT (n = 16)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Intraoral LLLT (n = 16)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (n = 16)
Number of subjects: 48
Study: 18467115

Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg/day
Number of subjects: 44

Group type: COMPARATOR
Intervention: Risedronate 5 mg/day (Control)
Number of subjects: 44
Study: 15986863

Group type: EXPERIMENTAL
Intervention: Partially hydrolyzed guar gum (PHGG) 10 g/day
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Partially hydrolyzed guar gum (PHGG) 5 g/day
Number of subjects: 86
Study: 12841561

Group type: EXPERIMENTAL
Intervention: Sauna-bathing allowed from 3rd postoperative day
Number of subjects: 79

Group type: COMPARATOR
Intervention: Sauna-bathing prohibited until sutures were removed
Number of subjects: 79
Study: 10526823

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 30
Study: 8661571

Group type: EXPERIMENTAL
Intervention: Pirenzepine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Scopolamine methyl bromide (SMB)
Number of subjects: 60
Study: 2071787

Group type: EXPERIMENTAL
Intervention: WEB 2086 (10 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: WEB 2086 (40 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: WEB 2086 (100 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 6223692

Group type: EXPERIMENTAL
Intervention: Dichloromethylene diphosphonate (Cl2MDP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30959274

Group type: EXPERIMENTAL
Intervention: Self-help stress management intervention (workbook based on an integrative stress model framework)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Delayed intervention group (control)
Number of subjects: 82
Study: 29444787

Group type: EXPERIMENTAL
Intervention: Discharge follow-up phone call
Number of subjects: 0
Study: 26472752

Group type: EXPERIMENTAL
Intervention: Obinutuzumab 2000 mg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Obinutuzumab 1000 mg
Number of subjects: 80
Study: 23775545

Group type: EXPERIMENTAL
Intervention: Facial reanimation surgery
Number of subjects: 90
Study: 22777298

Group type: EXPERIMENTAL
Intervention: Enteral Nutrition (EN)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Parenteral Nutrition (PN)
Number of subjects: 91
Study: 20420663

Group type: EXPERIMENTAL
Intervention: Portal survey technique including semi-structured questionnaires, breath alcohol test, drug assumption tests, and reaction time measurement using a driving simulator.
Number of subjects: 5000
Study: 18538773

Group type: EXPERIMENTAL
Intervention: 30 mL of 0.75% ropivacaine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 100
Study: 15660437

Group type: EXPERIMENTAL
Intervention: Bishop score
Number of subjects: 80

Group type: COMPARATOR
Intervention: Transvaginal ultrasound
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Bishop score and Transvaginal ultrasound
Number of subjects: 80
Study: 12687331

Group type: EXPERIMENTAL
Intervention: Nicotinamide
Number of subjects: 552
Study: 11146613

Group type: EXPERIMENTAL
Intervention: Epidural tramadol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 0
Study: 9333593

Group type: EXPERIMENTAL
Intervention: Magnesium treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Potassium and magnesium treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Magnesium application
Number of subjects: 0
Study: 8316579

Group type: EXPERIMENTAL
Intervention: Isometric training at 30 degrees knee flexion
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Isometric training at 60 degrees knee flexion
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Isometric training at 90 degrees knee flexion
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 107
Study: 3551602

Group type: EXPERIMENTAL
Intervention: Nifedipine (mean dose, 79.6 mg per day)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Propranolol (mean dose, 198.4 mg per day)
Number of subjects: 100
Study: 30316590

Group type: COMPARATOR
Intervention: 90:10 treatment (extruded high-fat pellet mixed with low-fat control pellet)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Extruded high-fat pellet inclusion
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 80:20 treatment
Number of subjects: 75

Group type: COMPARATOR
Intervention: 70:30 treatment, HFSP, and control
Number of subjects: 75

Group type: COMPARATOR
Intervention: 90:10 treatment
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Dietary fat inclusion (7% total fat)
Number of subjects: 75
Study: 28060791

Group type: EXPERIMENTAL
Intervention: Infant formula supplemented with prebiotics (FOS and GOS)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Infant formula supplemented with synbiotics (FOS/GOS and Lactobacillus paracasei ssp. paracasei strain F19)
Number of subjects: 182
Study: 26022195

Group type: EXPERIMENTAL
Intervention: Ligasure™ hemorrhoidectomy (Group 1, n = 26)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Milligan Morgan hemorrhoidectomy (Group 2, n = 28)
Number of subjects: 54
Study: 23273974

Group type: EXPERIMENTAL
Intervention: Active cost display group (5 imaging tests)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (5 imaging tests)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Active cost display group
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 10
Study: 21624240

Group type: EXPERIMENTAL
Intervention: Cod liver oil supplementation (0.5 g every 15 days for six times)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Corn oil (control)
Number of subjects: 100
Study: 18056271

Group type: EXPERIMENTAL
Intervention: FPV-RTV (700/100 mg BID) with 75% reduced RFB dose (150 mg QOD)
Number of subjects: 22

Group type: COMPARATOR
Intervention: RFB (300 mg QD)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Historical controls
Number of subjects: 22
Study: 16416154

Group type: EXPERIMENTAL
Intervention: ximelagatran (2x36 mg daily)
Number of subjects: 55

Group type: COMPARATOR
Intervention: enoxaparin/warfarin
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: ximelagatran (2x24 mg daily)
Number of subjects: 55

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 55
Study: 12789901

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 10832514

Group type: EXPERIMENTAL
Intervention: Misinformation presented by a partner during memory recall
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Accurate information presented by a partner during memory recall
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Discussion of crime with a partner who saw a slightly different sequence
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Confidence ratings of participants
Number of subjects: 0
Study: 9356766

Group type: EXPERIMENTAL
Intervention: Cold water (0.5 degree C; trial CD26)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Cool water (19 degrees C; trial CL26)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Water ingestion (any temperature)
Number of subjects: 7
Study: 8449013

Group type: EXPERIMENTAL
Intervention: 600 mg oral mifepristone
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 31208815

Group type: EXPERIMENTAL
Intervention: Bortezomib, thalidomide, and dexamethasone with daratumumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bortezomib, thalidomide, and dexamethasone without daratumumab
Number of subjects: 0
Study: 31308305

Group type: EXPERIMENTAL
Intervention: Isothermic blood cardioplegia (IBC)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Hypothermic blood cardioplegia (HBC)
Number of subjects: 48
Study: 27663190

Group type: EXPERIMENTAL
Intervention: 1g TXA intraoperative injection
Number of subjects: 198

Group type: COMPARATOR
Intervention: Placebo (normal saline injection)
Number of subjects: 198
Study: 27111466

Group type: EXPERIMENTAL
Intervention: Revised audiology report
Number of subjects: 32

Group type: COMPARATOR
Intervention: Unrevised audiology report
Number of subjects: 32
Study: 24356481

Group type: EXPERIMENTAL
Intervention: golimumab 100 mg + placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: golimumab + MTX
Number of subjects: 0

Group type: COMPARATOR
Intervention: golimumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo + MTX
Number of subjects: 0
Study: 22661243

Group type: EXPERIMENTAL
Intervention: 2.5 g/d fish oil (GA)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: 1.5 g/d fish oil (GB)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control (GC)
Number of subjects: 41
Study: 20833940

Group type: EXPERIMENTAL
Intervention: 5 mg of orally-disintegrating olanzapine
Number of subjects: 495

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 495
Study: 17008098

Group type: EXPERIMENTAL
Intervention: Serial casting
Number of subjects: 2

Group type: COMPARATOR
Intervention: Natural history (control)
Number of subjects: 2
Study: 16282288

Group type: EXPERIMENTAL
Intervention: Amodiaquine + Sulfadoxine-Pyrimethamine (AQ + SP)
Number of subjects: 944

Group type: EXPERIMENTAL
Intervention: Sulfadoxine-Pyrimethamine (SP)
Number of subjects: 944

Group type: EXPERIMENTAL
Intervention: Amodiaquine (AQ)
Number of subjects: 944
Study: 12110113

Group type: EXPERIMENTAL
Intervention: Zolmitriptan 2.5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zolmitriptan 1 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zolmitriptan 5 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9854511

Group type: EXPERIMENTAL
Intervention: TNF-SAM2, MCNU, and radiotherapy (TMR group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: MCNU and radiotherapy (MR group)
Number of subjects: 40
Study: 7832333

Group type: EXPERIMENTAL
Intervention: 10 micrograms/kg ondansetron
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: 50 micrograms/kg ondansetron
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: 100 micrograms/kg ondansetron
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study: 2186276

Group type: EXPERIMENTAL
Intervention: Geriatric assessment unit
Number of subjects: 155

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 155
Study: 355661

Group type: EXPERIMENTAL
Intervention: Oral bethanechol chloride (25 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral bethanechol chloride (50 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral bethanechol chloride (100 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30269231

Group type: EXPERIMENTAL
Intervention: HealthMpowerment.org (HMP) online intervention
Number of subjects: 474

Group type: EXPERIMENTAL
Intervention: HealthMpowerment.org (HMP) online intervention (for those using it for over 60 min)
Number of subjects: 474

Group type: COMPARATOR
Intervention: Information-only control website
Number of subjects: 474
Study: 29522897

Group type: EXPERIMENTAL
Intervention: Interdisciplinary behavioral intervention (PPACT) in conjunction with current health care services
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interdisciplinary behavioral intervention (PPACT)
Number of subjects: 0
Study: 26397405

Group type: EXPERIMENTAL
Intervention: Everolimus-Eluting Stent (EES)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Sirolimus-Eluting Stent (SES)
Number of subjects: 500
Study: 25153313

Group type: EXPERIMENTAL
Intervention: Preg CHAT (tailored SMS-texting intervention)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Txt4Baby (generic texting intervention)
Number of subjects: 35
Study: 22105435

Group type: EXPERIMENTAL
Intervention: Poractant alfa
Number of subjects: 126

Group type: COMPARATOR
Intervention: Beractant
Number of subjects: 126
Study: 19149706

Group type: EXPERIMENTAL
Intervention: High-resolution heart rate variability (HRV) analysis
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: High-resolution HRV analysis
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Nitroglycerin
Number of subjects: 273
Study: 17488381

Group type: EXPERIMENTAL
Intervention: SRL-ST group
Number of subjects: 430

Group type: COMPARATOR
Intervention: SRL-CsA-ST group
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 430
Study: 15114342

Group type: EXPERIMENTAL
Intervention: D-Amphetamine (AMPH) 0.25 mg/kg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 11822611

Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 16

Group type: COMPARATOR
Intervention: Dummy acupuncture
Number of subjects: 16

Group type: COMPARATOR
Intervention: Mock transelectrical nerve stimulation (TENS)
Number of subjects: 16
Study: 9627189

Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation (TMS) combined with noxious finger stimulation at an interstimulus interval of 100 ms
Number of subjects: 5

Group type: COMPARATOR
Intervention: Transcranial magnetic stimulation (TMS) applied alone
Number of subjects: 5